Prof. Francesca Spyrakis is full professor of Medicinal Chemistry at the Department of Drug Science and Technology at the University of Turin.
She works in the field of in silico drug design and discovery, applying and developing new methodologies for the identification of biologically active small molecules. Her research is mainly focused on the identification of new treatments and strategies to counteract antimicrobial resistance, and to inhibit the neuroinflammation induced by COVID-19 in the long term. She is the local coordinator of the UNITO unit within the ERASE Project.
ORCID: http://orcid.org/0000-0002-4016-227X
Email: francesca.spyrakis@unito.it